Please login to the form below

Not currently logged in
Email:
Password:

suptavumab

This page shows the latest suptavumab news and features for those working in and with pharma, biotech and healthcare.

US, EU regulators back rapid reviews of AZ’s RSV med

US, EU regulators back rapid reviews of AZ’s RSV med

Another rival, Regeneron’s antibody suptavumab (REGN2222), was dropped from development in 2017 after a late-stage trial failure.

Latest news

  • AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

    The prospects for both of AZ’s drugs for RSV prevention took an upturn last year, when a potential rival – Regeneron’s suptavumab – was dropped from development after missing its targets

  • Regeneron and Bayer drop AMD combination Regeneron and Bayer drop AMD combination

    This is the second pipeline disappointment for Regeneron in recent months after it abandoned respiratory syncytial virus (RSV) candidate suptavumab, which failed to hit the mark in a phase III trial

  • Regeneron drops RSV drug Regeneron drops RSV drug

    Suptavumab failed to prevent the infections in re-term infants. Regeneron has said it will end the development of its late-stage candidate for the prevention of respiratory syncytial virus (RSV) ... infection. The trial enrolled 1, 149 infants who were

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics